Halbert Hargrove Global Advisors, LLC Amgen Inc Transaction History

Halbert Hargrove Global Advisors, LLC

$1.81 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $4,741 - $5,779	-21 Reduced 1.65%	1,254 $303,000
Q4 2022 Jan 25, 2023	BUY	$229.03 - $291.01 $15,345 - $19,497	67 Added 5.55%	1,275 $0
Q3 2022 Oct 24, 2022	BUY	$224.46 - $253.15 $12,569 - $14,176	56 Added 4.86%	1,208 $272,000
Q2 2022 Aug 05, 2022	BUY	$230.71 - $256.74 $7,613 - $8,472	33 Added 2.95%	1,152 $280,000
Q1 2022 May 13, 2022	BUY	$219.27 - $242.57 $8,332 - $9,217	38 Added 3.52%	1,119 $271,000
Q4 2021 Feb 14, 2022	SELL	$198.88 - $227.6 $15,711 - $17,980	-79 Reduced 6.81%	1,081 $243,000
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $65,591 - $76,848	-309 Reduced 21.03%	1,160 $247,000
Q2 2021 Jul 29, 2021	BUY	$233.58 - $259.14 $73,344 - $81,369	314 Added 27.19%	1,469 $358,000
Q1 2021 May 06, 2021	BUY	$221.91 - $258.6 $6,435 - $7,499	29 Added 2.58%	1,155 $287,000
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $649 - $773	3 Added 0.27%	1,126 $259,000
Q3 2020 Nov 10, 2020	BUY	$234.65 - $260.95 $7,274 - $8,089	31 Added 2.84%	1,123 $285,000
Q2 2020 Aug 10, 2020	SELL	$197.81 - $242.74 $10,483 - $12,865	-53 Reduced 4.63%	1,092 $258,000
Q1 2020 May 01, 2020	BUY	$182.24 - $241.7 $6,013 - $7,976	33 Added 2.97%	1,145 $232,000
Q4 2019 Feb 12, 2020	SELL	$189.21 - $243.2 $12,298 - $15,808	-65 Reduced 5.52%	1,112 $268,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $13,406 - $16,063	77 Added 7.0%	1,177 $228,000
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $666 - $781	-4 Reduced 0.36%	1,100 $203,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $1,627 - $1,834	-9 Reduced 0.81%	1,104 $210,000
Q4 2018 Feb 11, 2019	BUY	$178.4 - $208.25 $535 - $624	3 Added 0.27%	1,113 $217,000
Q3 2018 Oct 31, 2018	SELL	$185.29 - $208.89 $9,449 - $10,653	-51 Reduced 4.39%	1,110 $230,000
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $1,992 - $2,238	-12 Reduced 1.02%	1,161 $214,000
Q1 2018 May 01, 2018	BUY	$169.43 - $198.0 $198,741 - $232,254	1,173 New	1,173 $200,000
Q4 2017 Feb 01, 2018	SELL	$168.79 - $188.59 $185,500 - $207,260	-1,099 Closed	0 $0
Q3 2017 Nov 02, 2017	BUY	$167.29 - $191.0 $183,851 - $209,909	1,099	1,099 $205,000

Others Institutions Holding AMGN

# of Institutions

3,123

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $150B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Halbert Hargrove Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Halbert Hargrove Global Advisors, LLC with notifications on news.

Account